Mayo Clinic will have four platform presentations and four poster presentations at the American Society of Cytopathology 60th Annual Scientific Meeting, held Nov. 2-6 in Las Vegas. For your reference, information about every Mayo Clinic speaker has been organized below (Mayo Clinic speakers are in italics).
|Title||How to Integrate Active Learning Pedagogies into Cytology Education: A Practical Guide to a Learner-Centered Approach|
|Date/Time||Nov. 2, 2012 from 10:30 a.m. - 12:30 p.m.|
|Moderator||Patricia G. Wasserman, MD|
|Speakers||David E. Elkowitz, DO; Leslie Dodd, MD; Lourdes R. Ylagan, MD; Aziza Nassar, MD; Samantha L. Butler, MD ; Deborah J. Chute, MD; Aylin Simsir, MD|
|Event Description||In order to facilitate active learning sessions, faculty must be trained in the techniques of Socratic questioning, recognize what a higher order conversation should look like, and be able to redirect discussions in real time without dominating them. This session will be a hands-on approach on how to organize and facilitate PBL session in Cytology education, with emphasis in faculty development. The audience will be divided in groups. There will be two members of the Cytopathology Program Directors Committee on each group acting as facilitators. The audience will receive pre-reading assignments. There will be pre- and post-exercise assessments. The audience will be guided on how to organize and facilitate a PBL session with a practical approach. There will be time for a question and answer at the end of the session.|
|Credit Hours||2.0 CME/CMLE|
|Title||Detection of Biliary Tract Malignancy: A Novel Method Using FISH, Cytomorphology and Statistical Programming|
|Date/Time||Nov. 3, 2012 from noon - 1:45 p.m.|
|Speakers||Amy Clayton, MD; Kevin C. Halling, MD, PhD|
|Event Description||Biliary strictures represent a clinical challenge as they can be associated with inflammatory conditions such as chronic pancreatitis, primary sclerosing cholangitis (PSC) or malignancy (pancreatic carcinoma or cholangiocarcinoma). Patients with PSC are at risk for developing cholangiocarcinoma thus compounding the challenge of determining which strictures are benign or malignant. Biopsy or brush cytology of the structured area has low sensitivity for the detection of malignancy (8-57% from literature review) due to both sampling and interpretation challenges. Fluorescence in situ hybridization (FISH) which detects cells with chromosomal abnormalities consistent with malignancy has been shown to improve the sensitivity of bladder cancer detection in urine cytology specimens. FISH applied to biliary brush specimens at our institution have been shown to also improve the diagnostic sensitivity and specificity for malignancy diagnosis. Currently, both conventional cytology and FISH are performed on all biliary brush specimens at our institution. Clinical follow-up on over 1000 patients with combined cytology and FISH analysis on biliary brush specimens has allowed us to create a statistical risk assessment for malignancy on each specimen based on a combination of patient age, PSC status, cytology result and FISH result. Having this unique data set with paired cytology slides has allowed us to identify cytology cases that were true interpretation errors (FISH positive, excluding sampling error). Analysis of this study set has allowed honing of cytomorphological skills to identify which features are most predictive of malignancy and which are nonspecific in biliary brush specimens. The combined use of both FISH and improved cytology skills has facilitated earlier diagnosis of malignancy offering potential for curative treatment, especially in patients with PSC. The panel luncheon presentation would focus on the most helpful cytomorphologic features for evaluating biliary brush specimens and the benefits of adding FISH analysis to further improve diagnostic accuracy.|
|Credit Hours||1.75 CME/CMLE/SAM|
|Title||What’s New in a Cytology Laboratory|
|Date/Time||Nov. 5, 2012 from noon – 1:45 p.m.|
|Speaker||Michael Henry, MD|
|Event Description||The changing face of medicine has had a significant impact on cytology and the roles of both cytopathologists and cytotechnologists in the laboratory. This round table will focus on a discussion of these roles as they have affected the cytopathology laboratory at the Mayo Clinic and how these changes may affect other laboratories both large and small.|
|Credit Hours||1.75 CME/CMLE|
|Title||DIAGNOSTIC CYTOLOGY SEMINAR|
|Date/Time||Nov. 5, 2012 from 2:00 – 3:30 p.m.|
|Moderator||Paul E. Wakely, Jr., MD|
|Panelists||Gladwyn Leiman, MBBCh, FIAC, FRCPath; Melissa L. Randolph, BS, CT(ASCP); Amy C. Clayton, MD; Joseph D. Jakowski, MD|
|Credit Hours||2.5 CME/CMLE/SAM|
Posters are viewed during all refreshment breaks:
Nov. 3, 2012 – 4:15 p.m. – 4:45 p.m.
Nov. 4, 2012 – 9:30 a.m. – 10:00 a.m. and 3:30 p.m. – 4:30 p.m.
Nov. 5, 2012 – 9:00 a.m. – 9:45 a.m.
|Improving Turnaround Time for Human Papilloma Virus Co-Testing on Women Thirty Years and Older at Mayo Clinic||Jessica Lesko|
|Validation of Videomicroscopy Support for Cytotechnologists During Rapid On-Site Evaluation of Endoscopic Ultrasound Guided Fine Needle Aspiration Specimens||Sarah Kerr, M.D.|
|Is it time to Revive Endometrial Brush Cytology as a Screening Test? A Feasibility Study of Permorance, Intraobserver Variability and Teachability||Sarah Kerr, M.D.|
|Renal Oncocytic Tumors- FNA Findings||Diva Salomao, M.D.|